with chronic heart failure.
FIBROBLASTS IN CARDIAC HOMEOSTASIS
Fibroblasts are defined and identified on the basis of functional and morphological criteria as cells of mesenchymal origin that lack a basement membrane and are involved in the formation and maintenance of connective tissues by producing a wide range of ECM proteins (9). Although several fibroblast markers have been proposed (Table 1) , their specificity is limited. Moreover, considering that resident fibroblast populations in many tissues are heterogeneous (10) and undergo dynamic phenotypic changes following injury, identification of reliable markers that label all fibroblast subsets is a major challenge. Humeres and Frangogiannis
Fibroblasts in Infarcted and Failing Hearts J U N E 2 0 1 9 : 4 4 9 -6 7 syncytium. Given their strategic location in the Vimentin Labels all fibroblasts (180, 181) . Also expressed by other cells of mesenchymal origin (endothelial cells [182] , vascular smooth muscle cells [183] , etc.).
a-SMA
Expressed by activated myofibroblasts in fibrotic hearts (22, 41, 138) . Not expressed by quiescent fibroblasts (137).
Also expressed by vascular mural cells.
Col1a1
Synthesis of structural collagens is a hallmark of fibroblasts in normal and remodeling hearts (42, 141) .
Although synthesis of structural collagens by cells other than fibroblasts has been reported, expression of Col1a1 in cardiac endothelial cells, immune cells, vascular smooth muscle cells, and pericytes is negligible when compared to fibroblasts (141) . Because of labeling of the surrounding matrix, antibodies to collagens may be suboptimal for fibroblast identification. Col1a1-GFP reporter mice represent a robust tool for identification of fibroblasts in many organs, including the heart (42).
Periostin
Expressed by fibroblasts in neonatal hearts but not by fibroblasts in normal adult hearts (184) . Highly expressed in activated cardiac fibroblasts after injury (185, 186) .
May also be expressed by subsets of vascular smooth muscle cells (187) .
Fibronectin ED-A Highly expressed by activated myofibroblasts (188) . Deposited in the matrix (189) . May also colocalize with macrophages, endothelial cells, and other cell types (190, 191) .
PDGFRa
Highly expressed in cardiac fibroblasts in normal (41) and pressureoverloaded myocardium (141) .
Although vascular smooth muscle cells have been reported to express PDGFRa, especially under conditions of stress (192) , PDGFRa-GFP reporter lines seem to predominantly identify cells with fibroblast-like characteristics (193) .
DDR2
High expression in cardiac fibroblasts in normal adult hearts (194) , colocalizing with vimentin and col1a1 (195) . May also be expressed in various subpopulations of infarct fibroblasts and myofibroblasts (196) .
DDR2 expression has been reported in activated endothelial cells (197) and in stretched vascular smooth muscle cells (198) . It is unclear whether this affects the specificity of DDR2 for fibroblasts in injured and remodeling hearts.
Antigen recognized by MEFSK4
The MEFSK4 antibody labels through flow cytometry almost all PDGFRaþ, Col1a1þ cardiac fibroblasts (14). No antibodies are available for immunohistochemistry.
MEFSK4 has been reported to label a small subpopulation of pericytes (14).
Cluster of differentiation 90 (Thy1)
Identifies a subpopulation of fibroblasts in the normal and remodeling myocardium (14, 141, 199, 200) .
Also expressed by immune cells, lymphatic endothelial cells, and pericytes (201) .
Sca1
Identifies a subpopulation (w60%) of PDGFRaþ, Col1a1þ fibroblasts in the murine heart (14).
Lacks specificity. In Sca1-GFP reporter mice, Sca1 expression colocalized with endothelial and pericyte markers (202) .
Tcf21
Labels the majority of fibroblast-like cells in normal myocardium (19) . In infarcted and pressure-overloaded hearts, accumulation of Tcf21þ fibroblast-like cells is noted; however, according to a single report, Tcf21 may not label activated a-SMAþ myofibroblasts (203).
Relatively specific for fibroblast populations. Not expressed by immune cells (CD45þ) (203), endothelial cells, and vascular smooth muscle cells (19) .
FSP1
No expression in fibroblasts in the normal adult myocardium. In the infarcted and pressure-overloaded heart, there is a marked expansion of FSP1þ cells. The majority of these cells cannot be identified as a-SMAþ myofibroblasts (141, 184) .
Lacks specificity. The majority of FSP1þ cells in injured and remodeling hearts are endothelial cells, macrophages, and vascular smooth muscle cells (184, 204) .
FAP
Not expressed in normal cardiac fibroblasts (174) . Labels many activated fibroblasts in infarcted rat hearts and in human myocardial samples from patients with post-infarction heart failure (205).
Specific for activated fibroblasts. However, in human failing hearts, FAP expression has been reported in small populations of inflammatory cells and endothelial cells (205) . 
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Fibroblasts in Infarcted and Failing Hearts In the dynamic environment of the infarcted heart, cardiac fibroblasts expand, undergo phenotypic changes, and are implicated in a wide range of functions. Coronary occlusion causes death of cardiomyocytes in the area of injury. During the inflammatory phase of infarct healing, Damage-Associated Molecular Patterns (DAMPs)
released by dying cells activate a pro-inflammatory phenotype in cardiac fibroblasts that secrete cytokines (such as IL-1, TNF-a, and GM-CSF), and chemokines (such as CCL2) contributing to recruitment and activation of leukocytes. Cytokine-stimulated fibroblasts also secrete matrix metalloproteinases (MMPs), promoting extracellular matrix degradation and release of pro-inflammatory matrix fragments. Some studies have suggested that infarct fibroblasts may also function as phagocytic cells; however, considering the abundance of macrophages in the healing infarct the relative contribution of "phagocytic fibroblasts" remains unclear.
Clearance of the infarcted heart from dead cells stimulates anti-inflammatory signals, leading to suppression of inflammation and transition to the proliferative phase of infarct healing. Fibroblasts expand, predominantly through recruitment of resident populations and undergo myofibroblast conversion, incorporating a-SMA into cytoskeletal stress fibers. Activated myofibroblasts are the main matrix-synthetic cells in the infarcted heart and produce both structural extracellular matrix proteins and matricellular macromolecules. In addition to their contribution in matrix production, fibroblast populations may also contribute to regulation of the angiogenic response and may regulate macrophage phenotype. During scar maturation fibroblasts exhibit disassembly of a-SMA-decorated stress fibers, and may produce matrix-crosslinking enzymes such as lysyl-oxidases (LOX). Reduction of fibroblast numbers in mature scars has been suggested to involve activation of apoptosis. The molecular basis for the phenotypic transitions of cardiac fibroblasts in the phases of infarct healing remains poorly understood. The functional diversity of fibroblasts in the infarcted heart may reflect sequential activation of distinct fibroblast subpopulations, or may result from coordinated responses of the fibroblasts to the dynamic changes in their microenvironment.
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Fibroblasts in Infarcted and Failing Hearts J U N E 2 0 1 9 : 4 4 9 -6 7 E x p a n s show reduced expression of a-SMA and express tendon genes.
The fate of fibroblasts was studied using 3 different lineage-tracing models: Tcf21 MCM/þ (resident cardiac fibroblasts), Postn-MCM (activated fibroblasts), and Acta2-CreERT2 (activated myofibroblasts).
Vimentin, a-SMA (206) Epicardial-derived resident mesenchymal cells, not bone marrow cells, are the main source of fibroblasts in the infarcted heart. WT1Cre mice were used for permanent genetic tracing of epicardium-derived cells. Mice reconstituted with RFP þ bone marrow cells were used to study bone marrow origin.
Collagen I, FSP1, DDR2, CD90, a-SMA (207) Following nonreperfused infarction, subsets of epicardiumderived cells differentiate into fibroblasts and smooth muscle cells.
Lineage tracing of epicardium derived cells by using inducible WT1 CreERT2 mice.
FSP1, procollagen I, collagen III,
The vast majority of activated collagen-producing fibroblasts (w96%) in nonreperfused infarcts are derived from epicardial cells. Hematopoietic, bone marrow lineages, and endothelial cells do not significantly contribute to the fibroblast population.
Lineage-tracing models to label epicardial cells (Wt1-Cre), endothelial cells (Tie2-Cre), hematopoietic cells (Vav-Cre). Transplantation with RFP þ bone marrow to study bone marrow origin.
Breeding with collagen 1a1-GFP reporter mice, a-SMA Humeres and Frangogiannis
were based on nonspecific Cre drivers (such as the Tie1-Cre line) (44) . Identification of fibroblasts represents another major challenge due to the absence of specific markers (Table 1) (56) and expression of specialized matrix proteins that locally activate or transduce growth factor-mediated signals (57). 
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